dalcetrapib
Showing 1 - 11 of 11
Covid19 Trial in Montréal (Dalcetrapib, Placebo)
Completed
- Covid19
- Dalcetrapib
- Placebo
-
Montréal, Quebec, CanadaInstitut de Cardiologie de Montréal
Nov 10, 2022
Acute Coronary Syndrome Trial in Canada, United States (Dalcetrapib, Placebo)
Not yet recruiting
- Acute Coronary Syndrome
- Dalcetrapib
- Placebo
-
Alexander City, Alabama
- +59 more
Jun 15, 2023
Healthy Volunteer Trial in Christchurch (atorvastatin, dalcetrapib)
Completed
- Healthy Volunteer
- atorvastatin
- dalcetrapib
-
Christchurch, New Zealand(unnamed)
Dec 13, 2019
Acute Coronary Syndrome Trial in Worldwide (dalcetrapib, Placebo)
Completed
- Acute Coronary Syndrome
- dalcetrapib
- Placebo
-
Alexander City, Alabama
- +562 more
Oct 9, 2022
Coronary Heart Disease Trial in Worldwide (dalcetrapib, )
Completed
- Coronary Heart Disease
- dalcetrapib
- placebo
-
Pensacola, Florida
- +32 more
Jul 17, 2019
Cardiovascular Disease Trial in Worldwide (Dalcetrapib, Placebo)
Terminated
- Cardiovascular Disease
- Dalcetrapib
- Placebo
-
Los Angeles, California
- +109 more
Mar 20, 2020
Coronary Heart Disease Trial in Germany, United States (Placebo, dalcetrapib)
Completed
- Coronary Heart Disease
- Placebo
- dalcetrapib
-
Chicago, Illinois
- +16 more
Jan 24, 2020
Coronary Heart Disease Trial in Worldwide (Placebo, dalcetrapib)
Completed
- Coronary Heart Disease
- Placebo
- dalcetrapib
-
Feldkirch, Austria
- +22 more
Dec 13, 2019
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Trial in Worldwide (Background
Completed
- Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
- Background care
- +2 more
-
Birmingham, Alabama
- +240 more
Nov 1, 2016